U.S. flag

An official website of the United States government, Department of Justice.

Prescription Drug Monitoring Program: Michigan State Profile (2021)

NCJ Number
Date Published
11 pages

The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Michigan state Prescription Drug Monitoring Program (PDMP).


The acronym of the Michigan PDMP is MAPS, and it is administered by the Bureau of Professional Licensing. The email address is provided, along with the URLs of the main website and related websites for enrollment, query, and data upload. Contact information is provided for the PDMP Manager and the PDMP specialist. In 2020, the state population was 10,084,442 and there were 52,433 DEA-registered prescribers and 2,548 DEA-registered dispensers. A total of 19 PDMP reports are available. PDMP funding for 2021 comes from the state general fund, controlled substance registration fees, and a CDC grant. Six employees perform operational tasks and six perform analytical/epidemiological work. Key dates are provided for significant developments in the PDMP, and access information is provided for statutes and rules relevant to PDMP responsibilities and procedures. Seventeen miscellaneous PDMP capabilities and policies are listed. The data retention policy is to retain only de-identified data. Training in the PDMP operation is available but not required for prescribers, dispensers, law enforcement personnel, the regulatory board, and the Attorney General. Requirements for having a PDMP account are reported. PDMP use by law enforcement agencies requires either an active investigation or a proper need/upon request. Access is by a written request and online/web portal. Criteria for conducting a query of the PDMP are reported. When prescribing controlled drugs, veterinarians must report required information on the animal and its owner. Data monitored or accessible pertain to drugs in Schedules II-V, naloxone/narcan administrations and dispensings, non-fatal overdoses, and pharmaceutical manufacturers/distributors sales. Information is provided on PDMP technological capabilities and types of requesters who can receive various types of reports.    

Date Published: January 1, 2021